PRINTER'S NO. 2394
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No.
459
Session of
2019
INTRODUCED BY STRUZZI, JOZWIAK, PASHINSKI, PICKETT AND
SCHLOSSBERG, SEPTEMBER 3, 2019
REFERRED TO COMMITTEE ON HEALTH, SEPTEMBER 3, 2019
A RESOLUTION
Urging the United States Food and Drug Administration to
promptly consider guidelines and protocols for the approval
of cannabidiol as a product which is legally available for
resale.
WHEREAS, The United States is seeing a change in the use of
marijuana for medical purposes; and
WHEREAS, Thirty-three states and the District of Columbia
have recognized that marijuana may have medical purposes; and
WHEREAS, This Commonwealth is one of the states which has
legalized the use of medical marijuana for limited purposes,
including serious medical conditions; and
WHEREAS, Under Federal law, the 2018 Farm Bill has created
additional questions with respect to the definition of marihuana
in Schedule I of the Controlled Substances Act; and
WHEREAS, Cannabidiol (CBD) is a product which can be derived
from a variety of marijuana plants, including, industrial hemp;
and
WHEREAS, The Federal Government has removed hemp and all
parts of the plant from the definition of marihuana in Schedule
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19